NDA Accepted for Adasuve for Agitation in Schizophrenia - MPR
Links shared publicly online about this topic.
- 61total visits
NDA Accepted for Adasuve for Agitation in Schizophrenia - MPR
empr.com —
Alexza Pharmaceuticals announced that the FDA has accepted its new drug application (NDA) for Adasuve (Staccato loxapine) for the rapid treatment of agitation in adults with schizophrenia.
View full resource at empr.com
Tags: Schizophrenia, Psychotic Disorder, Drug, Pharma, FDA
Most Recently Shared on August 19, 2011 at 4:02 pm By:
NDA Accepted for Adasuve for Agitation in Schizophrenia http://ow.ly/67DhH #schizophrenia
Advertisement
